| 2026-04-22 |
财报披露：
美东时间 2026-04-22 盘后发布财报
|
| 2026-04-01 |
详情>>
内部人交易：
BRASIER BARBARA L等共交易4笔
|
| 2026-03-23 |
股东大会：
将于2026-05-06召开股东大会
会议内容 ▼▲
- 1.To elect the ten director nominees named in this proxy statement to hold office until the 2027 annual meeting.
2.To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers.
3.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026.
4.To consider and approve an amendment to the Company’s 2025 Equity Incentive Plan to increase the number of shares available for issuance under such plan.
5.To consider and approve an amendment to the Company’s Certificate of Incorporation to permit stockholders to call special stockholders meetings.
|
| 2026-03-23 |
详情>>
股本变动：
变动后总股本5209.11万股
|
| 2026-02-10 |
详情>>
业绩披露：
2025年年报每股收益8.93美元,归母净利润4.72亿美元,同比去年增长-59.97%
|
| 2025-10-23 |
详情>>
业绩披露：
2025年三季报(累计)每股收益11.81美元,归母净利润6.32亿美元,同比去年增长-31.9%
|
| 2025-07-24 |
详情>>
业绩披露：
2025年中报每股收益10.23美元,归母净利润5.53亿美元,同比去年增长-8.14%
|
| 2025-04-24 |
详情>>
业绩披露：
2025年一季报每股收益5.47美元,归母净利润2.98亿美元,同比去年增长-1%
|
| 2025-03-17 |
股东大会：
将于2025-04-30召开股东大会
会议内容 ▼▲
- 1.To elect the nine director nominees named in this proxy statement to hold office until the 2026 annual meeting.
2.To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers.
3.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2025.
4.To consider and approve the Company’s 2025 Equity Incentive Plan.
5.To consider and vote upon a stockholder proposal regarding stockholders’ ability to call a special stockholders meeting, if properly presented.
|
| 2025-02-11 |
详情>>
业绩披露：
2024年年报每股收益20.52美元,归母净利润11.79亿美元,同比去年增长8.07%
|
| 2025-02-11 |
详情>>
业绩披露：
2022年年报每股收益13.72美元,归母净利润7.92亿美元,同比去年增长20.18%
|
| 2024-10-24 |
详情>>
业绩披露：
2023年三季报(累计)每股收益15.18美元,归母净利润8.75亿美元,同比去年增长18.89%
|
| 2024-10-24 |
详情>>
业绩披露：
2024年三季报(累计)每股收益16.05美元,归母净利润9.28亿美元,同比去年增长6.06%
|
| 2024-07-25 |
详情>>
业绩披露：
2024年中报每股收益10.38美元,归母净利润6.02亿美元,同比去年增长-4.44%
|
| 2024-04-25 |
详情>>
业绩披露：
2024年一季报每股收益5.21美元,归母净利润3.01亿美元,同比去年增长-6.23%
|
| 2024-03-21 |
股东大会：
将于2024-05-01召开股东大会
会议内容 ▼▲
- 1.To elect the nine directors named in this proxy statement to hold office until the 2025 annual meeting.
2.To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers.
3.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2024.
4.To consider and vote upon the shareholder proposal regarding simple majority voting, if properly presented.
|
| 2024-02-13 |
详情>>
业绩披露：
2023年年报每股收益18.91美元,归母净利润10.91亿美元,同比去年增长37.75%
|
| 2023-03-20 |
股东大会：
将于2023-05-03召开股东大会
会议内容 ▼▲
- 1.To elect nine directors to hold office until the 2024 annual meeting.
2.To consider and approve, on a non-binding advisory basis, the compensation of our named executive officers.
3.To conduct an advisory vote on the frequency of a stockholder vote on the compensation of our named executive officers.
4.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2023.
5.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2022-03-23 |
股东大会：
将于2022-05-04召开股东大会
会议内容 ▼▲
- 1.To elect nine directors to hold office until the 2023 annual meeting.
2.To consider and approve, on a non-binding advisory basis, the compensation of our named executive officers.
3.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2022.
4.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-03-22 |
股东大会：
将于2021-05-06召开股东大会
会议内容 ▼▲
- 1.To elect three Class I and three Class III directors to hold office until the 2022 annual meeting.
2.To consider and approve, on a non-binding advisory basis, the compensation of our named executive officers.
3.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2021.
4.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2020-03-24 |
股东大会：
将于2020-05-07召开股东大会
会议内容 ▼▲
- 1.To elect three Class III directors to hold office until the 2021 annual meeting.
2.To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers
3.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2020
4.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2019-03-25 |
股东大会：
将于2019-05-08召开股东大会
会议内容 ▼▲
- 1.To elect three Class II directors to hold office until the 2022 annual meeting.
2.To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers.
3.To adopt amendments to the Company’s Certificate of Incorporation, as amended, to phase out and eliminate the classified Board of Directors to provide for the annual election of all directors.
4.To approve the Molina Healthcare, Inc. 2019 Equity Incentive Plan.
5.To approve the Molina Healthcare, Inc. 2019 Employee Stock Purchase Plan.
6.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2019.
7.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2018-03-19 |
股东大会：
将于2018-05-02召开股东大会
会议内容 ▼▲
- 1.To elect three Class I directors to hold office until the 2021 annual meeting.
2.To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers.
3.To approve an amendment and restatement of our Bylaws to implement proxy access.
4.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2018.
5.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2017-05-03 |
复牌提示：
2017-05-02 12:51:51 停牌，复牌日期 2017-05-02 13:33:16
|
| 2017-03-13 |
股东大会：
将于2017-05-03召开股东大会
会议内容 ▼▲
- 1.To elect three Class III directors to hold office until the 2020 annual meeting.
2.To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers.
3.To conduct an advisory vote on the frequency of a stockholder vote on the compensation of our named executive officers.
4.To approve an amendment and restatement of the Molina Healthcare, Inc. 2011 Equity Incentive Plan (the “Equity Incentive Plan”) and re-approve the material terms of the performance goals for Section 162(m)(1) awards under the Equity Incentive Plan.
5.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2017.
6.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|